Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levornidazole Disodium Phosphate PK in Elderly vs Young Adults
CTR20232217Phase 4Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levornidazole disodium phosphate in amebiasis, surgical site infection (SSI), sponsored by Yangtze River Pharmaceutical Group. Started Jul 2023; status: completed.
02
Drugs
levornidazole disodium phosphate
03
Conditions
amebiasissurgical site infection (SSI)
Beyond the preview
Go deeper on CTR20232217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232217.